LOS ANGELES–(BUSINESS WIRE)–$LHSIF #ClassAction—The
Schall Law Firm, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of
Liberty Health Sciences Inc. (“Liberty Health” or “the Company”) (OTC: LHSIF)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
The investigation focuses on whether the Company issued false and/or
misleading statements and/or failed to disclose information pertinent to
investors. Aphria announced that it had sold its stake in Liberty Health
in September 2018. Quintessential Capital Management and Hindenburg
Research issued a report on December 3, 2018, that claimed Aphria had
developed a scheme to profit from the acquisition of shell companies at
improper prices. The scheme allegedly also involved Liberty Health.
Based on the report, Liberty Health’s stock price fell by 34% over the
next several trading days.
If you are a shareholder who suffered a loss, click
here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm’s website at www.schallfirm.com,
or by email at firstname.lastname@example.org.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.